US5811447A
(en)
|
1993-01-28 |
1998-09-22 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US6515009B1
(en)
|
1991-09-27 |
2003-02-04 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
USRE39049E1
(en)
|
1992-07-28 |
2006-03-28 |
Eli Lilly And Company |
Methods for inhibiting bone loss
|
USRE38968E1
(en)
|
1992-07-28 |
2006-02-07 |
Eli Lilly And Company |
Methods for inhibiting bone loss using 6-hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl-4-[2-(piperidin-1-yl) ethoxyphenylimethanone hydrochloride
|
TW366342B
(en)
*
|
1992-07-28 |
1999-08-11 |
Lilly Co Eli |
The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
|
US5770609A
(en)
|
1993-01-28 |
1998-06-23 |
Neorx Corporation |
Prevention and treatment of cardiovascular pathologies
|
US6395494B1
(en)
|
1993-05-13 |
2002-05-28 |
Neorx Corporation |
Method to determine TGF-β
|
US6251920B1
(en)
|
1993-05-13 |
2001-06-26 |
Neorx Corporation |
Prevention and treatment of cardiovascular pathologies
|
US6491938B2
(en)
|
1993-05-13 |
2002-12-10 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US6197789B1
(en)
|
1995-06-07 |
2001-03-06 |
Neorx Corporation |
Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
|
US6319914B1
(en)
|
1993-11-05 |
2001-11-20 |
Apollo Biopharmaceuticals, Inc. |
Cytoprotective effect of polycyclic phenolic compounds
|
US5554601A
(en)
*
|
1993-11-05 |
1996-09-10 |
University Of Florida |
Methods for neuroprotection
|
US6417198B1
(en)
|
1993-12-21 |
2002-07-09 |
Eli Lilly And Company |
Methods of inhibiting CNS problems in post-menopausal women
|
US5578613A
(en)
*
|
1993-12-21 |
1996-11-26 |
Eli Lilly And Company |
Methods for inhibiting weight gain or inducing weight loss
|
US5811120A
(en)
*
|
1994-03-02 |
1998-09-22 |
Eli Lilly And Company |
Solid orally administerable raloxifene hydrochloride pharmaceutical formulation
|
US5478847A
(en)
|
1994-03-02 |
1995-12-26 |
Eli Lilly And Company |
Methods of use for inhibiting bone loss and lowering serum cholesterol
|
US5972383A
(en)
*
|
1994-03-02 |
1999-10-26 |
Eli Lilly And Company |
Solid orally administerable raloxifene hydrochloride pharmaceutical formulation
|
US5502074A
(en)
*
|
1994-08-22 |
1996-03-26 |
Eli Lilly And Company |
Benzothiophenes for bone healing and fracture repair
|
EP0804202A4
(en)
*
|
1994-09-09 |
1999-01-13 |
Procter & Gamble |
Estrogens and parathyroid hormone for the treatment of osteoporosis
|
US6562862B1
(en)
|
1994-10-20 |
2003-05-13 |
Eli Lilly And Company |
Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y
|
CN1173819A
(zh)
*
|
1995-02-06 |
1998-02-18 |
伊莱利利公司 |
抑制il-6作用的方法
|
JP3263598B2
(ja)
*
|
1995-11-01 |
2002-03-04 |
有限会社ドット |
経鼻吸収用生理活性ペプチド組成物
|
AU761274B2
(en)
*
|
1996-01-29 |
2003-05-29 |
Schering Aktiengesellschaft |
Pharmaceutical combination preparation that consists of LHRH-analogues and antiestrogens for treating gynecological disorders
|
HN1996000101A
(es)
|
1996-02-28 |
1997-06-26 |
Inc Pfizer |
Terapia combinada para la osteoporosis
|
IL120270A0
(en)
*
|
1996-02-28 |
1997-06-10 |
Pfizer |
Combination therapy to treat osteoporosis
|
US6117911A
(en)
*
|
1997-04-11 |
2000-09-12 |
Neorx Corporation |
Compounds and therapies for the prevention of vascular and non-vascular pathologies
|
SE9702401D0
(sv)
*
|
1997-06-19 |
1997-06-19 |
Astra Ab |
Pharmaceutical use
|
EP1721617A3
(en)
*
|
1997-07-22 |
2008-05-28 |
Chugai Seiyaku Kabushiki Kaisha |
Dental therapeutics containing parathyroid hormone
|
CA2306344A1
(en)
*
|
1997-10-14 |
1999-04-22 |
Masahiko Sato |
Method of building and maintaining bone
|
US6054446A
(en)
|
1997-12-24 |
2000-04-25 |
Sri International |
Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
|
US20040176470A1
(en)
*
|
1998-05-07 |
2004-09-09 |
Steiner Mitchell S. |
Method for treatment and chemoprevention of prostate cancer
|
US20040033950A1
(en)
*
|
2000-09-26 |
2004-02-19 |
Hock Janet M. |
Method of increasing bone toughness and stiffness and reducing fractures
|
CA2346695A1
(en)
*
|
1998-10-07 |
2000-04-13 |
The Board Of Trustees Of The University Of Arkansas |
Methods of screening for apoptosis-controlling agents for bone anabolic therapies and uses thereof
|
US6416737B1
(en)
|
1998-11-19 |
2002-07-09 |
Board Of Trustees Of The University Of Arkansas |
Increasing bone strength with selected bisphosphonates
|
US20040214889A1
(en)
*
|
1999-07-31 |
2004-10-28 |
Smithkline Beecham Corporation |
Calcilytic compounds
|
CA2387693A1
(en)
*
|
1999-09-20 |
2001-03-29 |
Eli Lilly And Company |
Method for monitoring treatment with a parathyroid hormone
|
DE60116520T2
(de)
*
|
2000-10-10 |
2006-08-31 |
Microchips, Inc., Bedford |
Microchip-reservoir-vorrichtungen mit drahtloser übertragung von energie und daten
|
US20030216358A1
(en)
*
|
2001-07-05 |
2003-11-20 |
Muchmore Douglas Boyer |
Method for enhancing bone mineral density gain
|
US20050080143A1
(en)
*
|
2001-11-29 |
2005-04-14 |
Steiner Mitchell S. |
Treatment of androgen-deprivation induced osteoporosis
|
US20070197664A1
(en)
*
|
2001-11-29 |
2007-08-23 |
Steiner Mitchell S |
Prevention and treatment of androgen-deprivation induced osteoporosis
|
US20060269611A1
(en)
*
|
2001-11-29 |
2006-11-30 |
Steiner Mitchell S |
Prevention and treatment of androgen-deprivation induced osteoporosis
|
US20040214898A1
(en)
*
|
2001-11-29 |
2004-10-28 |
Steiner Mitchell S. |
Methods for treating hot flashes
|
US20080249183A1
(en)
*
|
2001-11-29 |
2008-10-09 |
Steiner Mitchell S |
Treatment of androgen-deprivation induced osteoporosis
|
EP1666033B1
(en)
*
|
2001-11-29 |
2008-12-31 |
GTX, Inc. |
Prevention and treatment of androgen-deprivation induced osteoporosis
|
US7247609B2
(en)
*
|
2001-12-18 |
2007-07-24 |
Universitat Zurich |
Growth factor modified protein matrices for tissue engineering
|
CN1658868A
(zh)
*
|
2002-06-13 |
2005-08-24 |
惠氏公司 |
巴泽昔芬治疗方案
|
JP3887588B2
(ja)
*
|
2002-08-30 |
2007-02-28 |
株式会社リガク |
X線回折による応力測定法
|
AU2003278766A1
(en)
*
|
2002-09-04 |
2004-03-29 |
Microchips, Inc. |
Method and device for the controlled delivery of parathyroid hormone
|
US7344716B2
(en)
*
|
2003-05-13 |
2008-03-18 |
Depuy Spine, Inc. |
Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
|
US7553827B2
(en)
*
|
2003-08-13 |
2009-06-30 |
Depuy Spine, Inc. |
Transdiscal administration of cycline compounds
|
US7429378B2
(en)
*
|
2003-05-13 |
2008-09-30 |
Depuy Spine, Inc. |
Transdiscal administration of high affinity anti-MMP inhibitors
|
US8273347B2
(en)
|
2003-05-13 |
2012-09-25 |
Depuy Spine, Inc. |
Autologous treatment of degenerated disc with cells
|
US20040229878A1
(en)
*
|
2003-05-13 |
2004-11-18 |
Depuy Spine, Inc. |
Transdiscal administration of specific inhibitors of P38 kinase
|
US20060106010A1
(en)
*
|
2003-05-27 |
2006-05-18 |
Black Larry J |
Methods for inhibiting bone loss
|
US8361467B2
(en)
*
|
2003-07-30 |
2013-01-29 |
Depuy Spine, Inc. |
Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
|
US8895540B2
(en)
|
2003-11-26 |
2014-11-25 |
DePuy Synthes Products, LLC |
Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
|
RU2006123939A
(ru)
*
|
2004-01-13 |
2008-02-20 |
Вайет (Us) |
Лечение остеопороза, связанного с терапией ингибиторами ароматазы
|
WO2005112984A2
(en)
*
|
2004-05-13 |
2005-12-01 |
Alza Corporation |
Apparatus and method for transdermal delivery of parathyroid hormone agents
|
US7531518B2
(en)
*
|
2004-05-14 |
2009-05-12 |
Unigene Laboratories Inc. |
Method for fostering bone formation and preservation
|
US7648965B2
(en)
*
|
2004-05-14 |
2010-01-19 |
Unigene Laboratories Inc. |
Method for fostering bone formation and preservation
|
US8575101B2
(en)
|
2005-01-06 |
2013-11-05 |
Kuros Biosurgery Ag |
Supplemented matrices for the repair of bone fractures
|
WO2006073711A2
(en)
*
|
2005-01-06 |
2006-07-13 |
Kuros Biosurgery Ag |
Use of a matrix comprising a contrast agent in soft tissues
|
US7488316B2
(en)
*
|
2005-01-25 |
2009-02-10 |
Microchips, Inc. |
Control of drug release by transient modification of local microenvironments
|
US20080076975A1
(en)
*
|
2005-01-25 |
2008-03-27 |
Microchips, Inc. |
Method and implantable device with reservoir array for pre-clinical in vivo testing
|
US20060293667A1
(en)
*
|
2005-05-19 |
2006-12-28 |
Agnes Vignery |
Bone implant device and methods of using same
|
US7691105B2
(en)
*
|
2005-09-26 |
2010-04-06 |
Depuy Spine, Inc. |
Tissue augmentation, stabilization and regeneration technique
|
US20070088436A1
(en)
|
2005-09-29 |
2007-04-19 |
Matthew Parsons |
Methods and devices for stenting or tamping a fractured vertebral body
|
US20070173447A1
(en)
*
|
2005-10-25 |
2007-07-26 |
Nastech Pharmaceutical Company Inc. |
Method for treating osteoporosis by intranasal delivery of teriparatide with an anti-resorptive agent
|
EP1945245A2
(en)
*
|
2005-11-10 |
2008-07-23 |
The Board of Control of Michigan Technological University |
Black bear parathyroid hormone and methods of using black bear parathyroid hormone
|
US20070168041A1
(en)
*
|
2006-01-17 |
2007-07-19 |
Sudhakar Kadiyala |
Method and instruments for intervertebral disc augmentation through a pedicular approach
|
WO2009131553A2
(en)
|
2006-12-29 |
2009-10-29 |
Osteogenex Inc. |
Methods of altering bone growth by administration of sost or wise antagonist or agonist
|
MX2009011005A
(es)
|
2007-04-13 |
2009-11-02 |
Kuros Biosurgery Ag |
Sellador polimerico para tejido.
|
US8241363B2
(en)
|
2007-12-19 |
2012-08-14 |
Depuy Spine, Inc. |
Expandable corpectomy spinal fusion cage
|
US8241294B2
(en)
*
|
2007-12-19 |
2012-08-14 |
Depuy Spine, Inc. |
Instruments for expandable corpectomy spinal fusion cage
|
US20090162351A1
(en)
*
|
2007-12-21 |
2009-06-25 |
Depuy Spine, Inc. |
Transdiscal administration of inhibitors of p38 MAP kinase
|
US8986696B2
(en)
*
|
2007-12-21 |
2015-03-24 |
Depuy Mitek, Inc. |
Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints
|
US8876905B2
(en)
*
|
2009-04-29 |
2014-11-04 |
DePuy Synthes Products, LLC |
Minimally invasive corpectomy cage and instrument
|
AU2009356227A1
(en)
|
2009-12-07 |
2012-06-21 |
Michigan Technological University |
Black bear parathyroid hormone and methods of using black bear parathyroid hormone
|
WO2011128424A1
(en)
*
|
2010-04-16 |
2011-10-20 |
Novartis Ag |
Methods and compositions for improving implant osseointegration
|
ES2882852T3
(es)
|
2011-03-16 |
2021-12-02 |
Kuros Biosurgery Ag |
Formulación farmacéutica para la utilización en la fusión espinal
|
EP3151847B1
(en)
*
|
2014-06-04 |
2020-07-29 |
Cedars-Sinai Medical Center |
Human mesenchymal stem cells and pth for use in a method for non surgical repair of vertebral compression fractures
|
GB2590692A
(en)
*
|
2019-12-24 |
2021-07-07 |
Corthotec Ltd |
Composition for improved bone fracture healing
|